CHIVD CHEMCLIN DIAGNOSTICS CORPORATION
DEAD

Serial Number

90265690

Owner

CHEMCLIN DIAGNOSTICS CO., LTD.

Attorney

Leo M. Loughlin

Filing Date

Oct 20, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CHIVD CHEMCLIN DIAGNOSTICS CORPORATION Trademark

Serial Number: 90265690

CHIVD CHEMCLIN DIAGNOSTICS CORPORATION is a trademark filed by CHEMCLIN DIAGNOSTICS CO., LTD. on October 20, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

CHEMCLIN DIAGNOSTICS CO., LTD. (2 trademarks)

7 FENGXIAN M. RD., YONGFENG BASE,
BEIJING 100094 , CN

Entity Type: 99

Trademark Details

Filing Date

October 20, 2020

Registration Date

Not Registered

Published for Opposition

June 1, 2021

Goods & Services

Diagnostic preparations for medical purposes; Diagnostic biomarker reagents for medical purposes; Biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Diagnostic reagents and contrast media for medical use; Diagnostic agents, preparations and substances for medical purposes; Diagnostic reagents for medicinal use; Diagnostic preparations for medical or veterinary purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes and hepatic fibrosis; Medical diagnostic reagents for the analysis of body fluids; Medical diagnostic reagents; Reagents and media for medical and veterinary diagnostic purposes; Pharmaceutical preparations for medical purposes for detecting the presence of cardiac, inflammation, fertility, infectious diseases, thyroid, tumor markers, diabetes, TORCH

Medical devices for use in treating or diagnosing thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes and hepatic fibrosis; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Hematology analyzers for medical diagnostic uses; Medical diagnostic apparatus for detecting cancer; Diagnostic apparatus for the detection of cancer; Medical instrument for cardiovascular diagnostics; Medical diagnostic instruments for the analysis of body fluids; Medical diagnostic apparatus for testing DNA, protein, Antigen, antibody, whole blood, serum and plasma; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical diagnostic apparatus, analytical apparatus for medical purposes and blood pressure measuring apparatus; Medical apparatus and instruments for detecting the presence of cardiac, inflammation, fertility, infectious diseases, thyroid, tumor markers, diabetes, TORCH

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Mar 4, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 4, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 24, 2023 EXRA
SOU EXTENSION 4 GRANTED
May 22, 2023 EX4G
SOU EXTENSION 4 FILED
May 22, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
May 22, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 20, 2023 EXRA
SOU EXTENSION 3 GRANTED
Jan 18, 2023 EX3G
SOU EXTENSION 3 FILED
Jan 18, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 18, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 19, 2022 EXRA
SOU EXTENSION 2 GRANTED
Jul 15, 2022 EX2G
SOU EXTENSION 2 FILED
Jul 15, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 15, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 21, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jan 19, 2022 EX1G
SOU EXTENSION 1 FILED
Jan 19, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 19, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 27, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 1, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 1, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 12, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 26, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 26, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 26, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 26, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 26, 2021 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 24, 2021 GNRN
NON-FINAL ACTION E-MAILED
Mar 24, 2021 GNRT
NON-FINAL ACTION WRITTEN
Mar 24, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 20, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 9, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 8, 2020 NWOS
NEW APPLICATION ENTERED
Oct 23, 2020 NWAP